Glioblastoma: exosome and microRNA as novel diagnosis biomarkers.

scientific article published on 11 November 2016

Glioblastoma: exosome and microRNA as novel diagnosis biomarkers. is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1038/CGT.2016.48
P698PubMed publication ID27834360

P50authorMohsen MohammadiQ54279945
Hamed MirzaeiQ63675145
P2093author name stringS M Mousavi
M Goodarzi
S Fadaei
J Verdi
E Fadaee
L Saadatpour
R Nassiri Mansour
P2860cites workExosomes: vehicles for the transfer of toxic proteins associated with neurodegenerative diseases?Q21129257
miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cellsQ21245271
Advanced health biotechnologies in Thailand: redefining policy directionsQ21245493
MiR-221 and miR-222 target PUMA to induce cell survival in glioblastomaQ21245708
miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesisQ24604354
Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkersQ24614672
A systematic review of microRNA in glioblastoma multiforme: micro-modulators in the mesenchymal mode of migration and invasionQ24633772
Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancerQ24645528
The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivoQ24657924
Glioblastoma: a pathogenic crosstalk between tumor cells and pericytesQ27320839
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cellsQ27860960
RNA-quality control by the exosomeQ28251052
Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastomaQ28261810
Extensive modulation of a set of microRNAs in primary glioblastomaQ28263314
Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapyQ28279046
microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastomaQ28280337
MiR-15b and miR-152 reduce glioma cell invasion and angiogenesis via NRP-2 and MMP-3Q28564217
microRNA-148a is a prognostic oncomiR that targets MIG6 and BIM to regulate EGFR and apoptosis in glioblastomaQ30407637
Oncogenic effects of miR-10b in glioblastoma stem cellsQ30414066
microRNA-34a is tumor suppressive in brain tumors and glioma stem cellsQ30428366
miR-195, miR-455-3p and miR-10a( *) are implicated in acquired temozolomide resistance in glioblastoma multiforme cells.Q34113732
Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases.Q34159409
Identification of MMP-9 specific microRNA expression profile as potential targets of anti-invasion therapy in glioblastoma multiformeQ34207182
Serial selection for invasiveness increases expression of miR-143/miR-145 in glioblastoma cell linesQ34226918
MicroRNAs/TP53 feedback circuitry in glioblastoma multiformeQ34262423
Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastomaQ34381578
MiR-328 expression is decreased in high-grade gliomas and is associated with worse survival in primary glioblastomaQ34450679
The CREB-miR-9 negative feedback minicircuitry coordinates the migration and proliferation of glioma cellsQ34490171
Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancerQ34736348
MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells.Q34819445
MiR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a platform for glioblastoma biomarker developmentQ35036059
Body fluid derived exosomes as a novel template for clinical diagnosticsQ35054648
MiR-330-mediated regulation of SH3GL2 expression enhances malignant behaviors of glioblastoma stem cells by activating ERK and PI3K/AKT signaling pathwaysQ35149540
Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease.Q35672459
Reduced expression of tissue factor pathway inhibitor-2 contributes to apoptosis and angiogenesis in cervical cancerQ35858377
MicroRNA expression profiling identifies miR-328 regulates cancer stem cell-like SP cells in colorectal cancerQ35859038
VHL regulates the effects of miR-23b on glioma survival and invasion via suppression of HIF-1α/VEGF and β-catenin/Tcf-4 signalingQ36127410
cAMP response element-binding protein promotes gliomagenesis by modulating the expression of oncogenic microRNA-23aQ36300857
Loss of miR-204 expression enhances glioma migration and stem cell-like phenotypeQ36544941
Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patientsQ36552755
Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of gliomaQ36560956
Tumour exosome integrins determine organotropic metastasis.Q36677568
miR-92b controls glioma proliferation and invasion through regulating Wnt/beta-catenin signaling via Nemo-like kinaseQ36792756
miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of gliomaQ37191655
Biological gene delivery vehicles: beyond viral vectorsQ37412239
Ionizing radiation and glioblastoma exosomes: implications in tumor biology and cell migrationQ37474338
MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activationQ37492137
MicroRNA involvement in glioblastoma pathogenesisQ37518235
STAT3 regulation of glioblastoma pathogenesis.Q37550760
MicroRNAs and glioblastoma: roles in core signalling pathways and potential clinical implicationsQ37857375
Exosomes as nano-theranostic delivery platforms for gene therapyQ38028323
Glioblastoma: from molecular pathology to targeted treatmentQ38128382
The potential for circulating microRNAs in the diagnosis of myocardial infarction: a novel approach to disease diagnosis and treatmentQ38631508
Epi-Drugs and Epi-miRs: Moving Beyond Current Cancer TherapiesQ38660013
MicroRNAs as potential diagnostic and prognostic biomarkers in melanomaQ38676204
Curcumin: A new candidate for melanoma therapy?Q38859978
Differential Effects of MicroRNAs on Glioblastoma Growth and MigrationQ39219681
MiR-24 regulates the proliferation and invasion of glioma by ST7L via β-catenin/Tcf-4 signalingQ39247010
miR-125b regulates the proliferation of glioblastoma stem cells by targeting E2F2.Q39274141
MiR-410 regulates MET to influence the proliferation and invasion of gliomaQ39322020
MiR-483-5p suppresses the proliferation of glioma cells via directly targeting ERK1.Q39371347
MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status.Q39528026
Interaction of hsa-miR-381 and glioma suppressor LRRC4 is involved in glioma growthQ39571222
MiR-136 promotes apoptosis of glioma cells by targeting AEG-1 and Bcl-2.Q39613855
Radiation-induced micro-RNA modulation in glioblastoma cells differing in DNA-repair pathwaysQ39716770
Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell-derived Exosomes to Glioblastoma Multiforme Cells Conferred ChemosensitivityQ39776996
Astrocytes and Glioblastoma cells release exosomes carrying mtDNA.Q39812809
MicroRNA-15b regulates cell cycle progression by targeting cyclins in glioma cellsQ39896800
The Exosome Is Recruited to RNA Substrates through Specific Adaptor ProteinsQ40596532
MiR-195, miR-196b, miR-181c, miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patientsQ44273844
Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkersQ84564273
Regulated microRNAs in the CSF of patients with multiple sclerosis: a case-control studyQ85217159
P433issue12
P407language of work or nameEnglishQ1860
P921main subjectbiomarkerQ864574
glioblastomaQ282142
microRNAQ310899
P304page(s)415-418
P577publication date2016-11-11
P1433published inCancer Gene TherapyQ15763088
P1476titleGlioblastoma: exosome and microRNA as novel diagnosis biomarkers
P478volume23

Reverse relations

cites work (P2860)
Q39368829Angiogenesis biomarkers and their targeting ligands as potential targets for tumor angiogenesis.
Q40072469Anoikis resistance and oncoviruses.
Q39038155Anti-Atherosclerotic Effects of Vitamins D and E in Suppression of Atherogenesis
Q91840508Cancer stem cells and oral cancer: insights into molecular mechanisms and therapeutic approaches
Q52564605Chronic obstructive pulmonary disease: MicroRNAs and exosomes as new diagnostic and therapeutic biomarkers.
Q60045517Deep sequencing of circulating exosomal microRNA allows non-invasive glioblastoma diagnosis
Q47396804Design, expression and evaluation of novel chimeric protein constructed from colorectal tumor-associated antigen
Q41928848Diet and cancer prevention: Dietary compounds, dietary MicroRNAs, and dietary exosomes.
Q41557851Exosomal miRNAs and miRNA dysregulation in cancer-associated fibroblasts
Q90657489Exosomal noncoding RNAs in Glioma: biological functions and potential clinical applications
Q54966511Exosomes in melanoma: a role in tumor progression, metastasis and impaired immune system activity.
Q33791231Exosomes: A Novel Strategy for Treatment and Prevention of Diseases
Q39395324Exosomes: promising sacks for treating ischemic heart disease?
Q64064460Expression of miR-26b in ovarian carcinoma tissues and its correlation with clinicopathology
Q47711872Extracellular Vesicles and the Promise of Continuous Liquid Biopsies
Q64052645Glioma stem cells-derived exosomal miR-26a promotes angiogenesis of microvessel endothelial cells in glioma
Q98159054Identification of glioblastoma-specific prognostic biomarkers via an integrative analysis of DNA methylation and gene expression
Q58748866Inhibition of microRNA-299-5p sensitizes glioblastoma cells to temozolomide via the MAPK/ERK signaling pathway
Q39157824Integrating liquid biopsies into the management of cancer
Q92408819Isolation and Analysis of Plasma-Derived Exosomes in Patients With Glioma
Q39432344Mesenchymal stem cells: A new platform for targeting suicide genes in cancer.
Q48095332MiR-21: A key player in glioblastoma pathogenesis.
Q64880476MicroRNA-559 plays an inhibitory role in the malignant progression of glioblastoma cells by directly targeting metadherin.
Q39375777MicroRNA: A novel target of curcumin in cancer therapy
Q39076551MicroRNA: Relevance to stroke diagnosis, prognosis, and therapy
Q39402059MicroRNAs in retinoblastoma: Potential diagnostic and therapeutic biomarkers.
Q39090370MicroRNAs: Potential candidates for diagnosis and treatment of colorectal cancer.
Q90384864Microfluidic Exponential Rolling Circle Amplification for Sensitive microRNA Detection Directly from Biological Samples
Q48157286Molecular aspects of diabetes mellitus: Resistin, microRNA, and exosome
Q39202038NLRP3 inflammasome: Its regulation and involvement in atherosclerosis
Q39329359Nanoparticles as new tools for inhibition of cancer angiogenesis
Q39315148Plasminogen Activator Inhibitor Type-1 as a Regulator of Fibrosis.
Q46556374Regulation of tumor-stroma interactions by the Unfolded Protein Response.
Q93226940Role of RNA-binding proteins during the late stages of Flavivirus replication cycle
Q98195525Role of exosomes in malignant glioma: microRNAs and proteins in pathogenesis and diagnosis
Q91741329Roles of Non-Coding RNAs in Normal Human Brain Development, Brain Tumor, and Neuropsychiatric Disorders
Q52646452Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme.
Q39085428State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia
Q39329517Stem Cell Therapy: A New Therapeutic Option for Cardiovascular Diseases.
Q38789375Stroke in Women: Risk Factors and Clinical Biomarkers.
Q39285733Therapeutic application of multipotent stem cells
Q64319932Ultracentrifugation versus kit exosome isolation: nanoLC-MS and other tools reveal similar performance biomarkers, but also contaminations

Search more.